• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

路易体痴呆患者基底核苍白球复合体 I 减少:路易体的作用。

Complex I reductions in the nucleus basalis of Meynert in Lewy body dementia: the role of Lewy bodies.

机构信息

Wellcome Centre for Mitochondrial Research, Newcastle University, Newcastle upon Tyne, UK.

Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.

出版信息

Acta Neuropathol Commun. 2020 Jul 9;8(1):103. doi: 10.1186/s40478-020-00985-8.

DOI:10.1186/s40478-020-00985-8
PMID:32646480
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7346628/
Abstract

Neurons of the nucleus basalis of Meynert (nbM) are vulnerable to Lewy body formation and neuronal loss, which is thought to underlie cognitive dysfunction in Lewy body dementia (LBD). There is continued debate about whether Lewy bodies exert a neurodegenerative effect by affecting mitochondria, or whether they represent a protective mechanism. Therefore, the present study sought to determine whether the nbM is subject to mitochondrial dysfunctional in LBD and the association of Lewy body formation with such changes. Post-mortem nbM tissue was stained for Complex I or IV and quantitated relative to porin with immunofluorescence using confocal microscopy of individual cells from LBD (303 neurons, 8 cases), control (362 neurons, 8 cases) and asymptomatic incidental LBD (iLBD) cases (99 neurons, 2 cases). Additionally, α-synuclein, tau and amyloid-β pathology were analysed using quantitative immunohistochemistry, and respiratory chain markers were compared in cells with Lewy bodies (N = 134) and unaffected cells (N = 272). The expression of Complex I normalised to mitochondrial mass was significantly lower in LBD compared to control and iLBD cases and this was unrelated to local neuropathological burdens but trended toward a relationship with neuronal loss. Furthermore, Complex I expression was higher in cells with Lewy bodies compared to adjacent cells without α-synuclein aggregates. These findings suggest that Complex I deficits in the nbM occur in symptomatic LBD cases and may relate to neuronal loss, but that contrary to the view that Lewy body formation underlies neuronal dysfunction and damage in LBD, Lewy bodies are associated with higher Complex I expression than neurons without Lewy bodies. One could speculate that Lewy bodies may provide a mechanism to encapsulate damaged mitochondria and/or α-synuclein oligomers, thus protecting neurons from their cytotoxic effects.

摘要

基底核内梅内尔特核(nbM)的神经元易受路易体形成和神经元丢失的影响,这被认为是路易体痴呆(LBD)认知功能障碍的基础。目前仍在争论路易体是否通过影响线粒体发挥神经退行性作用,还是它们代表一种保护机制。因此,本研究旨在确定 LBD 中 nbM 是否存在线粒体功能障碍,以及路易体形成与这种变化的关系。使用共聚焦显微镜对来自 LBD(303 个神经元,8 例)、对照(362 个神经元,8 例)和无症状偶发性 LBD(iLBD)病例(99 个神经元,2 例)的单个细胞进行免疫荧光染色,检测 nbM 组织中复合物 I 或 IV 的染色,并相对于孔蛋白进行定量。此外,使用定量免疫组织化学分析α-突触核蛋白、tau 和淀粉样β病理学,并比较具有路易体(N=134)和无路易体(N=272)的细胞中的呼吸链标志物。与对照和 iLBD 病例相比,LBD 中复合物 I 的表达归一化到线粒体质量显著降低,这与局部神经病理学负担无关,但与神经元丢失呈趋势相关。此外,与相邻无α-突触核蛋白聚集的细胞相比,具有路易体的细胞中复合物 I 的表达更高。这些发现表明,nbM 中的复合物 I 缺陷发生在有症状的 LBD 病例中,可能与神经元丢失有关,但与路易体形成是 LBD 中神经元功能障碍和损伤的基础这一观点相反,路易体与无路易体的神经元相比,表达更高的复合物 I。人们可以推测,路易体可能提供了一种机制来包裹受损的线粒体和/或α-突触核蛋白寡聚物,从而保护神经元免受其细胞毒性作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa8/7346628/6328f5bfa152/40478_2020_985_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa8/7346628/9ae082d45faf/40478_2020_985_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa8/7346628/a46244155237/40478_2020_985_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa8/7346628/6328f5bfa152/40478_2020_985_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa8/7346628/9ae082d45faf/40478_2020_985_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa8/7346628/a46244155237/40478_2020_985_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa8/7346628/6328f5bfa152/40478_2020_985_Fig3_HTML.jpg

相似文献

1
Complex I reductions in the nucleus basalis of Meynert in Lewy body dementia: the role of Lewy bodies.路易体痴呆患者基底核苍白球复合体 I 减少:路易体的作用。
Acta Neuropathol Commun. 2020 Jul 9;8(1):103. doi: 10.1186/s40478-020-00985-8.
2
Colocalization of tau and alpha-synuclein epitopes in Lewy bodies.路易小体中tau蛋白和α-突触核蛋白表位的共定位。
J Neuropathol Exp Neurol. 2003 Apr;62(4):389-97. doi: 10.1093/jnen/62.4.389.
3
Proteasomal abnormalities in cortical Lewy body disease and the impact of proteasomal inhibition within cortical and cholinergic systems.皮质路易体病中的蛋白酶体异常以及蛋白酶体抑制对皮质和胆碱能系统的影响。
J Neural Transm (Vienna). 2008 Jun;115(6):869-78. doi: 10.1007/s00702-008-0027-6. Epub 2008 Apr 10.
4
Regional Overlap of Pathologies in Lewy Body Disorders.路易体障碍中病理学的区域重叠
J Neuropathol Exp Neurol. 2017 Mar 1;76(3):216-224. doi: 10.1093/jnen/nlx002.
5
Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.路易体疾病谱系中脑和小脑中的路易体和阿尔茨海默病样病理特征
Neuropathol Appl Neurobiol. 2016 Aug;42(5):451-62. doi: 10.1111/nan.12308. Epub 2016 Apr 1.
6
Lewy Bodies and the Mechanisms of Neuronal Cell Death in Parkinson's Disease and Dementia with Lewy Bodies.路易小体与帕金森病和路易体痴呆中神经元细胞死亡的机制
Brain Pathol. 2017 Jan;27(1):3-12. doi: 10.1111/bpa.12344. Epub 2016 Jan 18.
7
Age- and disease-dependent increase of the mitophagy marker phospho-ubiquitin in normal aging and Lewy body disease.年龄和疾病依赖性磷酸泛素化标志在正常衰老和路易体病中的增加。
Autophagy. 2018;14(8):1404-1418. doi: 10.1080/15548627.2018.1461294. Epub 2018 Jul 28.
8
Cholinergic deficits and galaninergic hyperinnervation of the nucleus basalis of Meynert in Alzheimer's disease and Lewy body disorders.阿尔茨海默病和路易体病患者基底核内胆碱能缺陷和神经甘丙肽能神经支配过度。
Neuropathol Appl Neurobiol. 2020 Apr;46(3):264-278. doi: 10.1111/nan.12577. Epub 2019 Oct 1.
9
A soluble tau fragment generated by caspase-2 is associated with dementia in Lewy body disease.半胱天冬酶-2 产生的可溶tau 片段与路易体病痴呆相关。
Acta Neuropathol Commun. 2019 Jul 30;7(1):124. doi: 10.1186/s40478-019-0765-8.
10
Daytime sleepiness in dementia with Lewy bodies is associated with neuronal depletion of the nucleus basalis of Meynert.路易体痴呆患者的日间嗜睡与基底核 Meynert 核神经元缺失有关。
Parkinsonism Relat Disord. 2018 May;50:99-103. doi: 10.1016/j.parkreldis.2018.02.003. Epub 2018 Feb 3.

引用本文的文献

1
MicroRNAs and synaptic dysfunction in Parkinson's disease.帕金森病中的微小RNA与突触功能障碍
Mol Ther Nucleic Acids. 2025 Aug 12;36(3):102673. doi: 10.1016/j.omtn.2025.102673. eCollection 2025 Sep 9.
2
Current strategies in the management of dementia with lewy bodies and future directions based on disease pathophysiology.路易体痴呆的当前管理策略及基于疾病病理生理学的未来方向。
Mol Neurodegener. 2025 Jul 1;20(1):78. doi: 10.1186/s13024-025-00856-7.
3
Nucleus Basalis of Meynert Volume and Cognitive Impairment in Parkinson's Disease Before and After Deep Brain Stimulation of the Subthalamic Nucleus.

本文引用的文献

1
The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration.路易体的形成过程,而不仅仅是α-突触核蛋白的纤维化,是神经退行性变的主要驱动因素之一。
Proc Natl Acad Sci U S A. 2020 Mar 3;117(9):4971-4982. doi: 10.1073/pnas.1913904117. Epub 2020 Feb 19.
2
Cholinergic muscarinic M and M receptors as therapeutic targets for cognitive, behavioural, and psychological symptoms in psychiatric and neurological disorders.胆碱能毒蕈碱 M 和 M 受体作为治疗精神和神经疾病认知、行为和心理症状的靶点。
Drug Discov Today. 2019 Dec;24(12):2307-2314. doi: 10.1016/j.drudis.2019.08.009. Epub 2019 Sep 6.
3
帕金森病患者丘脑底核深部脑刺激前后Meynert基底核体积与认知障碍
Brain Sci. 2025 Jun 11;15(6):630. doi: 10.3390/brainsci15060630.
4
Combined Effects of Intermittent Hypoxia and Amyloid Beta on Hippocampal Activity, Its Cholinergic Modulation, and Memory.间歇性缺氧与β-淀粉样蛋白对海马体活动、胆碱能调节及其记忆的联合作用
Hippocampus. 2025 Jul;35(4):e70017. doi: 10.1002/hipo.70017.
5
Alpha-Synuclein Effects on Mitochondrial Quality Control in Parkinson's Disease.α-突触核蛋白对帕金森病中线粒体质量控制的影响
Biomolecules. 2024 Dec 22;14(12):1649. doi: 10.3390/biom14121649.
6
Modeling the neuroimmune system in Alzheimer's and Parkinson's diseases.在阿尔茨海默病和帕金森病中对神经免疫系统进行建模。
J Neuroinflammation. 2024 Jan 23;21(1):32. doi: 10.1186/s12974-024-03024-8.
7
Apoptotic Factors and Mitochondrial Complexes Assist Determination of Strain-Specific Susceptibility of Mice to Parkinsonian Neurotoxin MPTP.凋亡因子和线粒体复合物有助于确定帕金森病神经毒素 MPTP 对小鼠的菌株特异性易感性。
Mol Neurobiol. 2023 Aug;60(8):4778-4794. doi: 10.1007/s12035-023-03372-1. Epub 2023 May 10.
8
Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson's disease.α-突触核蛋白寡聚物与帕金森病路易体相关病理分布的差异。
Acta Neuropathol Commun. 2022 Sep 6;10(1):133. doi: 10.1186/s40478-022-01440-6.
9
Delineating selective vulnerability of inhibitory interneurons in Alpers' syndrome.阐明 Alpers 综合征中抑制性中间神经元的选择性易损性。
Neuropathol Appl Neurobiol. 2022 Oct;48(6):e12833. doi: 10.1111/nan.12833. Epub 2022 Jul 19.
10
Analysis of hemisphere-dependent effects of unilateral intrastriatal injection of α-synuclein pre-formed fibrils on mitochondrial protein levels, dynamics, and function.分析单侧纹状体注射α-突触核蛋白原纤维对线粒体蛋白水平、动态和功能的半球依赖性影响。
Acta Neuropathol Commun. 2022 May 23;10(1):78. doi: 10.1186/s40478-022-01374-z.
Cholinergic deficits and galaninergic hyperinnervation of the nucleus basalis of Meynert in Alzheimer's disease and Lewy body disorders.
阿尔茨海默病和路易体病患者基底核内胆碱能缺陷和神经甘丙肽能神经支配过度。
Neuropathol Appl Neurobiol. 2020 Apr;46(3):264-278. doi: 10.1111/nan.12577. Epub 2019 Oct 1.
4
Parkinson's disease biomarkers based on α-synuclein.基于α-突触核蛋白的帕金森病生物标志物。
J Neurochem. 2019 Sep;150(5):626-636. doi: 10.1111/jnc.14809. Epub 2019 Jul 28.
5
Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes.路易体病理存在于帕金森病中,由挤在一起的细胞器和脂膜组成。
Nat Neurosci. 2019 Jul;22(7):1099-1109. doi: 10.1038/s41593-019-0423-2. Epub 2019 Jun 24.
6
Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo.由单体生成α-突触核蛋白预形成纤维及其体内应用。
J Vis Exp. 2019 Jun 2(148). doi: 10.3791/59758.
7
Autophagy in Synucleinopathy: The Overwhelmed and Defective Machinery.自噬在突触核蛋白病中的作用:不堪重负和功能失调的机制。
Cells. 2019 Jun 9;8(6):565. doi: 10.3390/cells8060565.
8
Identification of a New α-Synuclein Aggregation Inhibitor via Mass Spectrometry Based Screening.基于质谱筛选鉴定新型α-突触核蛋白聚集抑制剂。
ACS Chem Neurosci. 2019 Jun 19;10(6):2683-2691. doi: 10.1021/acschemneuro.9b00092. Epub 2019 Jun 4.
9
Antibodies against alpha-synuclein: tools and therapies.抗α-突触核蛋白抗体:工具与疗法。
J Neurochem. 2019 Sep;150(5):612-625. doi: 10.1111/jnc.14713. Epub 2019 Jun 25.
10
Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration.致病的α-突触核蛋白聚集物优先与线粒体结合,并影响细胞呼吸。
Acta Neuropathol Commun. 2019 Mar 14;7(1):41. doi: 10.1186/s40478-019-0696-4.